◆ CONDITIONS WE TREAT / HEART ATTACK PREVENTION

Heart attacks are largely preventable.

A heart attack doesn’t have to be inevitable. With advanced testing and early intervention, we can identify hidden cardiovascular risk years before a cardiac event — and build a personalized strategy to keep your heart safe for decades to come.

Heart attacks are largely preventable

Every 40 seconds, someone in the United States has a heart attack. For many of them, that heart attack is their first symptom of heart disease — no warning, no chest pain beforehand, no indication that anything was wrong.

This is what makes heart attacks so terrifying: they seem to strike out of nowhere. But here’s what most people don’t understand. Heart attacks don’t happen suddenly — they’re the culmination of years or decades of silent disease progression. The damage was building all along. It just wasn’t being detected. Waiting for symptoms is not a prevention strategy.

50%
of all heart attacks occur in people with normal cholesterol levels — which is why screening cholesterol alone leaves you partially protected at best. Stampfer et al., NEJM

What actually causes a heart attack?

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. Without oxygen, the affected heart tissue begins to die within minutes. The longer the blockage persists, the greater the damage. But what causes that clot to form in the first place? This is where the conventional understanding falls short.

Most people assume heart attacks happen when plaque gradually narrows an artery until it finally closes off. In reality, most heart attacks are caused by plaque rupture, not gradual blockage. A vulnerable plaque with a thin, inflamed cap suddenly breaks open; the body forms a clot to seal the rupture; and that clot can completely block the artery within seconds.

This is why someone can have a “mild” blockage on an angiogram one month and a massive heart attack the next. The plaques most likely to rupture are often not the ones causing the most narrowing — they’re the inflamed, unstable ones that standard testing may miss entirely.

Why standard prevention falls short

Conventional heart attack prevention typically focuses on managing traditional risk factors: lowering LDL cholesterol, controlling blood pressure, and prescribing aspirin or statins. These interventions help — but they leave significant gaps. Consider these sobering facts:

  • Half of all heart attacks occur in people with normal cholesterol levels.
  • Many patients have heart attacks despite taking statins faithfully.
  • Standard stress tests miss up to 30% of significant coronary disease.
  • Risk calculators routinely underestimate risk in certain populations, including women and younger adults.

The problem isn’t that conventional medicine is wrong — it’s that it’s incomplete. Focusing only on LDL cholesterol while ignoring genetic drivers, inflammation, insulin resistance, particle characteristics, and plaque stability leaves you partially protected at best.

THE HIDDEN RISK FACTORS

What actually predicts a heart attack.

At our practice, we assess the factors most closely linked to plaque rupture and cardiac events — the drivers standard screening tends to miss.

01

Inflammation

Chronic inflammation destabilizes plaque and makes rupture more likely. Markers like hsCRP, Lp-PLA2, and MPO help us assess inflammatory burden in your arteries. Elevated inflammation dramatically increases heart attack risk — even when cholesterol looks acceptable.

02

Advanced Lipid Markers

Standard cholesterol panels tell only part of the story. We measure LDL particle number and size, because small, dense LDL particles are far more dangerous than large, buoyant ones. Two people with identical LDL cholesterol can carry vastly different risk.

03

Lipoprotein(a)

Lp(a) is a genetically determined risk factor affecting roughly one in five people. It significantly increases heart attack and stroke risk, yet most patients have never had it measured — and unlike standard cholesterol, it doesn’t respond to diet or statins.

04

Insulin Resistance

Metabolic dysfunction promotes inflammation, creates dangerous lipid patterns, and accelerates atherosclerosis. Many people have significant insulin resistance for years before their blood sugar becomes abnormal. Testing fasting insulin identifies this risk early.

05

Arterial Imaging

Blood tests reveal risk factors; imaging shows what’s actually happening in your arteries. A coronary artery calcium (CAC) score reveals whether plaque has formed, and CT angiography can identify the soft, vulnerable plaques most likely to rupture.

06

Additional Contributing Factors

Elevated homocysteine damages the arterial lining; oxidized LDL triggers inflammation; fibrinogen and clotting factors raise clot risk; sleep apnea creates repeated cardiovascular stress; and chronic cortisol elevation drives inflammation and metabolic dysfunction.

Warning signs you shouldn’t ignore

While many heart attacks occur without prior symptoms, some warning signs may appear in the days, weeks, or months beforehand:

  • Chest discomfort, pressure, or tightness, especially with exertion
  • Shortness of breath that’s new or worsening
  • Unusual fatigue, especially in women
  • Discomfort in the jaw, neck, shoulder, arm, or upper back
  • Lightheadedness or dizziness
  • Nausea or cold sweats without obvious cause
  • A sense that something is wrong, even if you can’t explain it
If you suspect a heart attack
If you experience symptoms of a heart attack, call 911 immediately. Do not drive yourself to the hospital — call 911 so treatment can begin en route.

The fear of the unknown

If heart disease runs in your family, or you’ve been told you have risk factors, you may carry a constant low-level anxiety about your heart. You wonder if every episode of indigestion might be something more. You think about whether you’ll be there to see your children grow up or enjoy your retirement. This fear is understandable — but living in fear without taking action only adds to your stress, which itself increases cardiovascular risk.

There’s another way. When you truly understand your cardiovascular status through comprehensive testing, fear transforms into knowledge — and knowledge gives you the power to act. Our patients consistently tell us that knowing their actual risk, even when the news isn’t perfect, feels better than wondering in the dark.

OUR APPROACH

Identify risk before damage occurs.

We take a comprehensive, proactive approach to preventing cardiac events — built on advanced testing and a personalized plan that targets your specific risk factors, not just the obvious ones.

STEP 1 · COMPREHENSIVE RISK ASSESSMENT

Testing that goes far beyond standard panels.

  • Inflammatory markers, including markers of vascular inflammation that predict plaque instability.
  • Advanced lipid analysis — particle number, size, and oxidized LDL.
  • Metabolic assessment to catch insulin resistance years before blood sugar rises.
  • Medical-grade genetic testing, including Lp(a).
  • Arterial imaging (CAC scoring, CT angiography) when indicated.
  • The goal: identify every significant risk factor, not just the obvious ones.
STEP 2 · PERSONALIZED PREVENTION PLAN

A strategy built around your results.

  • Anti-inflammatory nutrition proven to reduce inflammation and stabilize plaque.
  • Targeted supplementation — omega-3s, vitamin K2, CoQ10, and other cardioprotective nutrients.
  • Metabolic optimization to reverse insulin resistance and restore healthy blood sugar.
  • Blood pressure control that addresses root causes, not just the number.
  • Stress & sleep — calming the nervous system and treating sleep apnea.
  • Strategic medications, used precisely when your profile calls for them.

Prevention is ongoing — and your genes are not your destiny.

Prevention isn’t a one-time event. We monitor your progress with follow-up testing to ensure interventions are working, and as your body responds, we adjust the plan to optimize outcomes. Our Fit in Your GENES® Program provides the structure and support needed for lasting change.

And while genetics influence your baseline risk, lifestyle factors have an enormous impact. Studies show that even people with high genetic risk can reduce their heart attack risk by 50% or more through optimal lifestyle and medical management.

Who benefits most
Comprehensive prevention matters most if you have a family history of early heart attack; elevated cholesterol, blood pressure, or prediabetes; are a woman approaching or past menopause; carry weight around the midsection; live with high stress; have an elevated calcium score; have an inflammatory condition (rheumatoid arthritis, lupus, psoriasis); or simply want peace of mind about your cardiovascular future.
FREQUENTLY ASKED QUESTIONS

Heart attack prevention, answered.

01 I feel fine. Do I really need to worry about heart attack prevention? +
Unfortunately, feeling fine doesn’t mean you’re protected. Heart disease develops silently for years before causing symptoms. The time to prevent a heart attack is long before you feel anything is wrong — and comprehensive testing can reveal hidden risk even when you feel perfectly healthy.
02 My cholesterol is well controlled on medication. Isn’t that enough? +
Cholesterol control is important, but it’s only one piece of the puzzle. Many heart attacks occur in people with well-controlled cholesterol because inflammation, insulin resistance, and other risk factors were never addressed. Statins reduce risk by roughly 25–30%, which means significant residual risk remains.
03 At what age should I start thinking about heart attack prevention? +
Atherosclerosis can begin in your 20s and 30s, especially with risk factors. We recommend baseline advanced testing by age 40 for most adults — or earlier if you have a family history of premature heart disease, elevated Lp(a), or other significant risk factors.
04 Can heart attack risk really be reduced, or is it mostly genetic? +
While genetics influence your baseline risk, lifestyle factors have an enormous impact. Studies show that even people with high genetic risk can reduce their heart attack risk by 50% or more through optimal lifestyle and medical management. Your genes are not your destiny.
05 How often should I be tested? +
After initial comprehensive testing, we typically recommend blood work at 3–6 month intervals to monitor inflammatory and metabolic markers. Imaging tests like coronary calcium scoring are usually repeated every 3–5 years depending on your baseline and risk level. We’ll create a monitoring schedule tailored to your situation.
◆ DON’T WAIT FOR A WAKE-UP CALL

The best heart attack is the one that never happens.

A heart attack doesn’t have to be your first indication that something is wrong. With the right testing and a personalized prevention plan, you can identify and address risk factors years before they cause harm. Schedule a free Heart Health Strategy Session to review your history, answer your questions, and learn whether our approach is right for you.

Free, no-obligation strategy session.  ·  Call or text 877-511-5166

Speak with a Human →
EVIDENCE
Sources & Citations
+

Incidence, Symptoms & Acute MI

  1. American Heart Month — February 2019. MMWR Morb Mortal Wkly Rep. 2019;68(5):101.
  2. Fang J, Luncheon C, Ayala C, Odom E, Loustalot F. Awareness of Heart Attack Symptoms and Response Among Adults — United States, 2008, 2014, and 2017. MMWR Morb Mortal Wkly Rep. 2019;68(5):101–106.
  3. Anderson JL, Morrow DA. Acute Myocardial Infarction. N Engl J Med. 2017;376(21):2053–2064.

Cholesterol, Lipids & Residual Statin Risk

  1. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction. N Engl J Med. 1991;325(6):373–381.
  2. Durrington P. Dyslipidaemia. Lancet. 2003;362(9385):717–731.
  3. Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and PPAR-Alpha Agonists and Ezetimibe for Its Treatment. Int J Mol Sci. 2022;23(7):3418.
  4. Byrne P, Demasi M, Jones M, et al. Evaluating the Association Between LDL Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-Analysis. JAMA Intern Med. 2022;182(5):474–481.
  5. Collins R, Reith C, Emberson J, et al. Interpretation of the Evidence for the Efficacy and Safety of Statin Therapy. Lancet. 2016;388(10059):2532–2561.
Medically Reviewed
Reviewed by Dr. Regina Druz, MD, MBA, FACC, FMCP-M
Last reviewed: June 2026
Medical disclaimer. This content is for educational purposes and does not substitute for medical advice. If you are experiencing a medical emergency, call 911.

Learn More

Guides

Articles

Podcasts

Ep. 42: Small Dose, Big Power: Microdosing GLP-1 to Quell Midlife Inflammation — with Dr. Jennifer Roelands, Integrative Gynecologist

Posted on
0 Comments
Guest: Dr. Jennifer Roelands, MD — Integrative Gynecologist & Longevity Physician In this episode, Dr. Regina Druz is joined by Dr. Jennifer Roelands — a board-certified OB-GYN who practices integrative gynecology and longevity medicine — to reframe GLP-1 agonists (semaglutide and tirzepatide) as a form of hormonal replacement therapy rather than simple weight-loss drugs. They…